The Influence of Multimorbidity on Clinical Progression of Dementia in a Population-Based Cohort

Introduction Co-occurrence with other chronic diseases may influence the progression of dementia, especially in case of multiple chronic diseases. We aimed to verify whether multimorbidity influenced cognitive and daily functioning during nine years after dementia diagnosis compared with the influence in persons without dementia. Methods In the Kungsholmen Project, a population-based cohort study, we followed 310 persons with incident dementia longitudinally. We compared their trajectories with those of 679 persons without dementia. Progression was studied for cognition and activities of daily life (ADLs), measured by MMSE and Katz Index respectively. The effect of multimorbidity and its interaction with dementia status was studied using individual growth models. Results The mean (SD) follow-up time was 4.7 (2.3) years. As expected, dementia related to both the decline in cognitive and daily functioning. Irrespective of dementia status, persons with more diseases had significantly worse baseline daily functioning. In dementia patients having more diseases also related to a significantly faster decline in daily functioning. Due to the combination of lower functioning in ADLs at baseline and faster decline, dementia patients with multimorbidity were about one to two years ahead of the decline of dementia patients without any co-morbidity. In persons without dementia, no significant decline in ADLs over time was present, nor was multimorbidity related to the decline rate. Cognitive decline measured with MMSE remained unrelated to the number of diseases present at baseline. Conclusion Multimorbidity was related to baseline daily function in both persons with and without dementia, and with accelerated decline in people with dementia but not in non-demented individuals. No relationship of multimorbidity with cognitive functioning was established. These findings imply a strong interconnection between physical and mental health, where the greatest disablement occurs when both somatic and mental disorders are present.

[1]  R. Green,et al.  Population-based study of medical comorbidity in early dementia and "cognitive impairment, no dementia (CIND)": association with functional and cognitive impairment: The Cache County Study. , 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[2]  Sati Mazumdar,et al.  Rating chronic medical illness burden in geropsychiatric practice and research: Application of the Cumulative Illness Rating Scale , 1992, Psychiatry Research.

[3]  A. Burns.  Clinical diagnosis of Alzheimer's disease , 1991 .

[4]  J. Morris.  The Clinical Dementia Rating (CDR) , 1993, Neurology.

[5]  Janet B W Williams,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[6]  J. Morris,et al.  Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease: a clinical perspective of data from the Consortium to Establish a Registry for Alzheimer's Disease. , 1999, Archives of neurology.

[7]  Carol Brayne,et al.  Age, neuropathology, and dementia. , 2009, The New England journal of medicine.

[8]  B. Winblad,et al.  Patterns of Chronic Multimorbidity in the Elderly Population , 2009, Journal of the American Geriatrics Society.

[9]  B. Winblad,et al.  Clinical diagnosis of Alzheimer's disease and other dementias in a population survey. Agreement and causes of disagreement in applying Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition, Criteria. , 1992, Archives of neurology.

[10]  S. MacDonald,et al.  Trajectories of Cognitive Decline following Dementia Onset: What Accounts for Variation in Progression? , 2011, Dementia and Geriatric Cognitive Disorders.

[11]  B. Winblad,et al.  Occurrence of dementia in advanced age: the study design of the Kungsholmen Project. , 1992, Neuroepidemiology.

[12]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[13]  J A Knottnerus,et al.  Problems in determining occurrence rates of multimorbidity. , 2001, Journal of clinical epidemiology.

[14]  G. Trobozić.  [International classification of diseases, injuries and causes of death as a uniform standard in medicine]. , 1971, Narodno zdravlje.

[15]  Roberta F. White,et al.  The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort. , 2000, Archives of neurology.

[16]  K. Holmen,et al.  Prevalence of Alzheimer's disease and other dementias in an elderly urban population , 1991, Neurology.

[17]  L. Fratiglioni,et al.  Aging with multimorbidity: A systematic review of the literature , 2011, Ageing Research Reviews.

[18]  J A Knottnerus,et al.  Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. , 1998, Journal of clinical epidemiology.

[19]  J. Singer,et al.  Applied Longitudinal Data Analysis , 2003 .

[20]  S. Leurgans,et al.  Association of muscle strength with the risk of Alzheimer disease and the rate of cognitive decline in community-dwelling older persons. , 2009, Archives of neurology.

[21]  A. Hofman,et al.  Measuring Cognitive Function With Age: The Influence of Selection by Health and Survival , 2008, Epidemiology.

[22]  Alina Solomon,et al.  Comorbidity and the rate of cognitive decline in patients with Alzheimer dementia , 2011, International journal of geriatric psychiatry.

[23]  B. Winblad,et al.  Prevention of Alzheimer's disease and dementia. Major findings from the Kungsholmen Project , 2007, Physiology & Behavior.

[24]  M. V. van Boxtel,et al.  Influence of multimorbidity on cognition in a normal aging population: a 12‐year follow‐up in the Maastricht Aging Study , 2011, International journal of geriatric psychiatry.

[25]  Laura Fratiglioni,et al.  Prevalence of chronic diseases and multimorbidity among the elderly population in Sweden. , 2008, American journal of public health.

[26]  Yaakov Stern,et al.  Physical activity, diet, and risk of Alzheimer disease. , 2009, JAMA.

[27]  R. Green,et al.  Effects of general medical health on Alzheimer's progression: the Cache County Dementia Progression Study , 2012, International Psychogeriatrics.

[28]  J. Cummings,et al.  Prevalence and impact of medical comorbidity in Alzheimer's disease. , 2002, The journals of gerontology. Series A, Biological sciences and medical sciences.

[29]  L. Fratiglioni,et al.  Rate of cognitive decline in preclinical Alzheimer's disease: the role of comorbidity. , 2003, The journals of gerontology. Series B, Psychological sciences and social sciences.

[30]  G. Belle,et al.  Symptom Patterns and Comorbidity in the Early Stages of Alzheimer's Disease , 1994, Journal of the American Geriatrics Society.

[31]  M. V. van Boxtel,et al.  Multimorbidity and its relation to subjective memory complaints in a large general population of older adults , 2010, International Psychogeriatrics.

[32]  S. Katz,et al.  STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION. , 1963, JAMA.

[33]  V. Hachinski,et al.  Changing perspectives regarding late-life dementia , 2009, Nature Reviews Neurology.

[34]  Li Wang,et al.  Performance-based physical function and future dementia in older people. , 2006, Archives of internal medicine.